Robeco Institutional Asset Management B.V. lowered its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 33.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,512,798 shares of the company's stock after selling 770,261 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.19% of Colgate-Palmolive worth $119,541,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Capital Advisors Inc. OK grew its stake in Colgate-Palmolive by 1.4% in the fourth quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company's stock valued at $758,000 after purchasing an additional 129 shares in the last quarter. S.A. Mason LLC boosted its stake in shares of Colgate-Palmolive by 3.9% during the 3rd quarter. S.A. Mason LLC now owns 3,499 shares of the company's stock worth $280,000 after acquiring an additional 130 shares in the last quarter. Security National Bank of Sioux City Iowa IA boosted its stake in shares of Colgate-Palmolive by 0.8% during the 3rd quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company's stock worth $1,298,000 after acquiring an additional 130 shares in the last quarter. Stratos Wealth Advisors LLC boosted its stake in shares of Colgate-Palmolive by 4.5% during the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company's stock worth $241,000 after acquiring an additional 130 shares in the last quarter. Finally, Chicago Partners Investment Group LLC boosted its stake in shares of Colgate-Palmolive by 1.5% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 9,387 shares of the company's stock worth $724,000 after acquiring an additional 136 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.
Insider Buying and Selling
In other news, COO Panagiotis Tsourapas sold 35,000 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $94.61, for a total value of $3,311,350.00. Following the completion of the transaction, the chief operating officer directly owned 10,415 shares of the company's stock, valued at approximately $985,363.15. This represents a 77.07% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Stanley J. Sutula III sold 97,843 shares of the stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the transaction, the chief financial officer directly owned 55,310 shares of the company's stock, valued at approximately $5,214,073.70. The trade was a 63.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 184,683 shares of company stock valued at $17,486,693. 0.34% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Trading Down 0.0%
Colgate-Palmolive stock opened at $84.31 on Monday. The business has a 50 day moving average price of $90.94 and a two-hundred day moving average price of $83.61. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. The stock has a market cap of $67.64 billion, a price-to-earnings ratio of 32.18, a price-to-earnings-growth ratio of 3.89 and a beta of 0.34. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.91 by $0.04. The firm had revenue of $5.23 billion during the quarter, compared to analysts' expectations of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.91 EPS. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.
Colgate-Palmolive Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be issued a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Monday, April 20th. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.52. Colgate-Palmolive's payout ratio is currently 80.92%.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on CL. Piper Sandler cut their price objective on Colgate-Palmolive from $96.00 to $92.00 and set an "overweight" rating for the company in a research report on Wednesday, April 8th. Weiss Ratings reissued a "hold (c)" rating on shares of Colgate-Palmolive in a research report on Wednesday, January 21st. TD Cowen reaffirmed a "hold" rating and issued a $85.00 price target on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Citigroup upped their price target on Colgate-Palmolive from $95.00 to $105.00 and gave the company a "buy" rating in a report on Monday, February 2nd. Finally, The Goldman Sachs Group reaffirmed a "buy" rating and issued a $100.00 price target on shares of Colgate-Palmolive in a report on Friday, February 20th. Eleven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $96.13.
Check Out Our Latest Analysis on Colgate-Palmolive
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report